IL2 and lung cancer: M28z10 CAR-T cells exhibited enhanced and sustained antitumor activity against MSLN+ lung cancer cells in vitro, and the secretion of Interleukin-2 (IL-2), Interferon-γ (IFN-γ), granzyme B and granulocyte–macrophage colony-stimulating factor (GM-CSF) was increased.